Congenital Myasthenic Syndrome - 10 Studies Found
Completed |
: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes : Congenital Myasthenic Syndrome : 2010-09-15 : Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Recruiting |
: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS) :
|
Available |
: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome :
|
Available |
: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients :
|
Completed |
: Pregnancy Outcomes in Congenital Myasthenie Syndrome : Congenital Myasthenic Syndrome : 2011-11-16 |
Available |
: 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM) :
|
Recruiting |
: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes : Myasthenic Syndromes, Congenital : 2015-09-24 :
|
Recruiting |
: Ephedrine for the Treatment of Congenital Myasthenia : Myasthenic Syndromes, Congenital : 2007-10-07 : Drug: Ephedrine |
No longer available |
: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP : Lambert Eaton Myasthenic Syndrome (LEMS) : 2011-06-20 : Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |
Available |
: Treatment Use of 3,4-Diaminopyridine :
: 2013-01-06 :
|